NCT02245958已完成不适用
A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 44
- 主要终点
- Dose of Botulinum Toxin Used to Treat Cervical Dystonia
研究概览
简要总结
This study is a retrospective chart review to evaluate the doses of botulinum Type A toxins BOTOX® (onabotulinumtoxinA) and Xeomin® (incobotulinumtoxinA) used for the treatment of Cervical Dystonia and Blepharospasm in clinical practice.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Confirmed primary diagnosis of idiopathic cervical dystonia or blepharospasm for at least 2 years
- •Treatment with Xeomin® and BOTOX® for at least 2 years each.
排除标准
- •Having a neuromuscular junction transmission disorder or taking any medications that could affect neuromuscular junction transmission
- •Previous surgical procedure involving bone or muscle for the management of cervical dystonia or blepharospasm.
结局指标
主要结局
Dose of Botulinum Toxin Used to Treat Cervical Dystonia
时间窗: 4 Years
Dose of Botulinum Toxin Used to Treat Blepharospasm
时间窗: 4 Years
次要结局
- Botulinum Toxin Inter-injection Intervals(4 Years)
- Number of Participants with Adverse Events(4 Years)
- Annual Botulinum Toxin Dose per Patient(4 Years)
研究者
相似试验
已完成
不适用
A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and BlepharospasmCervical DystoniaBlepharospasmNCT01814774Allergan48
已完成
不适用
An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type AFacial RhytidesNCT01608659Allergan110
尚未招募
3 期
Evaluation of BTX Injections in Treatment of BruxismBruxismNCT05980559Alexandria University12
已完成
3 期
Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the FaceSkin AgingNCT00986570Biolab Sanus Farmaceutica121
已完成
3 期
IncobotulinumtoxinA (Xeomin) for Upper Limb SpasticityUpper Limb SpasticityNCT00465738Merz Pharmaceuticals GmbH216